The evidence against pharmacy benefit managers, or PBMs, has been piling up. Congress and multiple state legislatures have held hearings revealing how the anti-consumer practices of these health insurance corporate middlemen are driving up out-of-pocket prescription drug costs.
The Federal Trade Commission issued a report condemning PBM pricing manipulations. Media reports have detailed how these middlemen mark up drug prices and collect billions of dollars in hidden fees, increasing costs for patients and employers.
New polling has confirmed that the American people urgently want something done about this problem. And it may affect their votes in the November election....
Comments